LeMaitre attracts corporate heavyweight to board, audit group
This article was originally published in Clinica
Executive Summary
LeMaitre Vascular (Burlington, Massachusetts), a developer and manufacturer of devices for the treatment of peripheral vascular disease, has appointed John O’Connor to its board of directors; he will also serve as chair of the company’s audit committee. Mr O’Connor retired in 2006, before which he was vice-chairman of services for PricewaterhouseCoopers, where he was a partner for 24 years. The appointment should enable LeMaitre to "regain compliance with the Marketplace Rules of the Nasdaq Stock Market, which require that a majority of the company’s board of directors be independent and that the company’s audit committee be composed of three or more independent directors”. Mr O’Connor’s “strategic acumen” will be an “ideal complement” to those of other board members, said chairman and CEO George LeMaitre.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.